Financial reports
ARS
2023 FY
Annual report to shareholders
11 Apr 24
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Departure of Directors or Certain Officers
1 Apr 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
8-K
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
8-K
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
8 Jan 24
8-K
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
2 Nov 23
8-K
Entry into a Material Definitive Agreement
13 Sep 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
8-K
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
3 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
Registration and prospectus
S-3ASR
Automatic shelf registration
3 Aug 23
S-8
Registration of securities for employees
2 Jun 22
S-8
Registration of securities for employees
4 Aug 21
S-8
Registration of securities for employees
25 Feb 21
S-3ASR
Automatic shelf registration
6 Aug 20
S-8
Registration of securities for employees
6 Aug 20
S-3ASR
Automatic shelf registration
2 Jul 20
424B5
Prospectus supplement for primary offering
22 May 20
424B5
Prospectus supplement for primary offering
21 May 20
POS AM
Prospectus update (post-effective amendment)
11 Mar 20
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
16 Apr 21
DEFA14A
Additional proxy soliciting materials
22 May 20
Other
CT ORDER
Confidential treatment order
24 Jan 23
CT ORDER
Confidential treatment order
16 Jul 21
SEC STAFF
SEC staff action: Order
10 Mar 21
CT ORDER
Confidential treatment order
4 Mar 21
SEC STAFF
SEC staff action: Order
9 Feb 21
CT ORDER
Confidential treatment order
30 Sep 20
EFFECT
Notice of effectiveness
1 May 20
CT ORDER
Confidential treatment order
7 Nov 19
CT ORDER
Confidential treatment order
17 Apr 19
CT ORDER
Confidential treatment order
16 Apr 18
Ownership
3
John L Slebir
5 Apr 24
4
Justin Burgess
19 Mar 24
4
Justin Burgess
4 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
David F Novack
20 Feb 24
4
Ryan Spencer
20 Feb 24
4
Kelly MacDonald
20 Feb 24
4
Robert Janssen
20 Feb 24
4
Justin Burgess
20 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24